Immunogenicity of Botulinum Toxin Formulations: Potential Therapeutic Implications
Crossref DOI link: https://doi.org/10.1007/s12325-021-01882-9
Published Online: 2021-09-13
Published Print: 2021-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Carr, Warner W.
Jain, Neal
Sublett, J. Wesley
Funding for this research was provided by:
merz pharmaceuticals
Text and Data Mining valid from 2021-09-13
Version of Record valid from 2021-09-13
Article History
Received: 24 June 2021
Accepted: 2 August 2021
First Online: 13 September 2021